Stock Price
14.89
Daily Change
-0.11 -0.73%
Monthly
10.26%
Yearly
34.71%
Q1 Forecast
14.47

Amarin reported $20.8M in Ordinary Share Capital for its fiscal quarter ending in September of 2025.





Ordinary Share Capital Change Date
AbbVie USD 1.77B 1.75B Jun/2025
Alnylam Pharmaceuticals USD 131.79M 130.49M Sep/2025
Amarin USD 20.8M 28K Sep/2025
AstraZeneca USD 1.55B 1.16B Sep/2025
DBV Technologies USD 11.65M 1000 Mar/2025
GlaxoSmithKline GBP 4.03B 119.13M Sep/2025
Halozyme Therapeutics USD 117.52M 98K Sep/2025
Ionis Pharmaceuticals USD 161.14M 160.98M Sep/2025
Neurocrine Biosciences USD 99.7M 700K Sep/2025
Novartis USD 1.94B 23.4M Jun/2025